Combination therapies for metabolic dysfunction-associated steatohepatitis: challenges and opportunities.

已完结 10 由 kkkkkkk 发布于 2026/1/14 16:37:56

DOI:10.1136/gutjnl-2025-337431
作者：Xiao-Dong Zhou, Qiong-Yue Fan, Christopher D Byrne, Giovanni Targher, Mark D Muthiah, Daniel Q Huang, Qin-Fen Chen, Mazen Noureddin, Wenhao Li, Vlad Ratziu
文献类型：期刊论文
补充材料：只需要正文

BMJ

Abstract：Metabolic dysfunction-associated steatohepatitis (MASH) is a multifactorial metabolic liver disease that occurs in the context of obesity, insulin resistance and cardiometabolic comorbiditie

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Cambridge University PressCaffeic acid attenuates hydrogen peroxide-induced inflammation in porcine small intestinal epithelial cells by inhibiting nuclear factor kappa-B -mediated NOD-like receptor thermal protein domain associated protein 3 inflammasome activation.